Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × Folfox protocol × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 15 Colonic Neoplasms 4 Stomach Neoplasms 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Carcinoma, Non-Small-Cell Lung 3 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Pathologic Complete Response 1 Lung Neoplasms 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Colorectal Cancer Metastatic 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Breast Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

lutetium Lu 177 dotatate 3 pasireotide 2 Octreotide 2 lanreotide 1 copper dotatate CU-64 1 abemaciclib 1 Sunitinib 1 Receptor-Like Protein Tyrosine Phosphatases, Class 2 1 Lutetium-177 1 Lutetium 1 Everolimus 1 E-7386 1 Cryotherapy 1 Acupuncture Therapy 1 Acupressure 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡